Pharmacodynamic target attainment analysis against Streptococcus pneumoniae using levofloxacin 500mg, 750mg and 1000mg once daily in plasma (P) and epithelial lining fluid (ELF) of hospitalized patients with community acquired pneumonia (CAP)

Publication | Closed Access

DOI

Citations

References

2004

Year

Ayman Noreddin, Theodore K. Marras, Kevin Sanders, Charles K. Chan, Daryl J. Hoban, George G. Zhanel

International Journal of Antimicrobial Agents

Streptococcus PneumoniaeHealth SciencesAntimicrobial StewardshipAntibioticsMedicineEpithelial Lining FluidKlebsiella PneumoniaeLevofloxacin 500MgAntimicrobial ChemotherapyAntimicrobial PharmacokineticsInfection ControlAntimicrobial PharmacodynamicsPharmacologyClinical MicrobiologyAntimicrobial ResistancePharmacodynamic ModelingDrug Resistance